Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
Stock Information for Celcuity Inc.
Loading
Please wait while we load your information from QuoteMedia.